Eli Lilly & Co.
P/S (Price-to-Sales)
Price
Sales Per Share
P/S (Price-to-Sales)
| Fiscal Year | P/S (Price-to-Sales) | Sales Per Share | Price |
|---|---|---|---|
| Sep 2013 | 2.38x | $21.46 | $51.00 |
| Sep 2014 | 3.65x | $18.90 | $68.99 |
| Sep 2015 | 4.56x | $18.50 | $84.26 |
| Sep 2016 | 3.74x | $19.64 | $73.55 |
| Sep 2017 | 4.39x | $19.25 | $84.46 |
| Sep 2018 | 5.59x | $20.72 | $115.72 |
| Sep 2019 | 5.53x | $23.78 | $131.43 |
| Sep 2020 | 6.63x | $25.47 | $168.84 |
| Sep 2021 | 9.06x | $30.48 | $276.22 |
| Sep 2022 | 11.31x | $32.35 | $365.84 |
| Sep 2023 | 16.35x | $35.64 | $582.92 |
| Sep 2024 | 17.10x | $45.15 | $772.00 |
| Sep 2025 | 16.33x | $66.11 | $1,079.75 |